Wellbiotec Co., Ltd. (KOSE:A010600) announced a private placement of 6,764,374 common shares at an issue price of KRW 4,435 per share for gross proceeds of KRW 29,999,998,690 on January 2, 2019. The transaction will involve participation from new investors, MSTEch Korea Co., Ltd. and I Innovation Co., Ltd. for 3,382,187 shares each. The shares have face value of KRW 500 and are being issued at premium. The shares issued in the transaction will have a hold period of 12 months from the date of issuance. The company will issue shares through third-party allotment method. Prior to the transaction, the total number of shares issued by the company are 28,866,830 shares. The payment date is March 21, 2019. The transaction has been approved by the board of directors of the company.